Skip to main content
Equibles
EVH logo

EVH · Evolent Health, Inc.

Track EVH — free

Use EVH with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about EVH

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$4.74 +0.04 (+0.85%) At close · Aug 21
Market Cap
$520.07M
Shares
113.06M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.70 Open$4.52 Day$4.50–4.76 52W close$2.17–9.99 Avg vol 30d3.8M Short int15.8M · 14.0% float · 3.6d Short vol47% Last earningsAug 6, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Nov 5, 2026 Est · unconfirmed · in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 6, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Weak Quant / Vol Very High
      Market backdrop VIX 16 · calm Equity put/call 0.58
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +21%
      above
      Price vs 50-day avg −1%
      below
      RSI (14) 57
      neutral
      MACD trend Positive
      52-week position 32%
      mid-range
      Momentum
      relative strength
      Very Strong
      1-month return +1%
      trailing
      6-month return +45%
      trailing
      YTD return +18%
      this year
      Relative strength +33%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $5 › 200d $4 — 50d above 200d
      Institutional flow Accumulating
      +3% holders QoQ · +38 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      13.99% of float · ▲ +7.7% MoM · 3.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      199 holders — mid 3-yr range
      Squeeze score 61
      elevated · 0–100
      Fundamentals
      Weak
      Revenue growth −2%
      Y/Y
      EPS growth −526%
      Y/Y
      Free cash flow $3.3M
      Balance sheet $818.7M
      net debt
      Quant / Vol
      risk profile
      Very High
      Volatility 81%
      annualized · 1-yr
      Max drawdown −78%
      past year
      ATR 8.0%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 6 of last 6
      Latest guidance · from the 8-K filed Aug 6, 2026
      Revenue · 2026 $2.6B – $2.7B
      prior FY $1.88B midpoint +41.2% Y/Y
      Prior guidance period ended · from the 8-K filed Nov 6, 2025
      Revenue · three months ended December 31, 2025 $462M – $472M
      Guided vs delivered · last 6 settled
      Revenue three months ended December 31, 2025
      guided $462M – $472M
      $1.88B Beat +301.8%
      Revenues full-year
      guided $2.4B – $2.5B
      $2.55B Beat +4.3%
      Revenues first quarter
      guided $595M – $610M
      $639.65M Beat +6.2%
      Revenues full-year
      guided $1.95B – $1.97B
      $1.96B In line

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      0 · 4 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +21% Bullish
      Price vs 50-day avg
      −1% Neutral
      RSI (14)
      57 Neutral
      MACD trend
      Positive Bullish
      52-week position
      32% Neutral
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $5 › 200d $4 — 50d above 200d
      Institutional flow Accumulating
      +3% holders QoQ · +38 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      13.99% of float · ▲ +7.7% MoM · 3.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      199 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $2 Now $5 · 32% Range high $10
      vs 200-day avg +21% vs 50-day avg -1%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted Cost of Revenue non-GAAP $982.94M Six Months Ended June 30, 2026 —
      Adjusted Selling, General and Administrative Expenses non-GAAP $115.71M Six Months Ended June 30, 2026 —
      Average Lives on Platform - Administrative Services 1,221 FY2025 —
      Average Lives on Platform - Performance Suite 6,482 FY2025 —
      Average Lives on Platform - Specialty Technology and Services Suite 77,983 FY2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Health Information Services — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      EVH
      Evolent Health, Inc.
      this stock
      		$520.07M +17.5% -1.8% — 14.0%
      VEEV
      Veeva Systems Inc
      		 $40.70B +12.2% +28.1% 44.4 4.5%
      PMDIY
      Pro Medicus Ltd./ADR
      		 $13.02B -24.9% — — 0.0%
      TEM
      Tempus AI, Inc.
      		 $11.98B +12.9% +83.4% — 18.4%
      BTSG
      BrightSpring Health Services, Inc.
      		 $11.78B +59.0% +28.2% 36.1 4.2%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      199
      % held
      99.7%
      Net QoQ
      +1.7M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      160
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      15.8M
      Days to cover
      3.6d
      Change
      +1.1M sh
      View
      Short Volume
      Short vol %
      47%
      As of
      Aug 21, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      2
      Value
      $7
      As of
      Jul 30, 2026
      View
      Off-Exchange
      Off-exchange %
      34.2%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Sell
      Member
      Greg Gianforte
      Amount
      $50.0K–$100.0K
      Traded
      May 11, 2020
      View
      Financials
      Financials
      Revenue (FY)
      $1.9B
      Net income (FY)
      $-534.5M
      EPS diluted
      $-5.07
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 6, 2026
      This year
      8
      View
      Proposed Sales
      Value
      $93.9K
      Shares
      9.2K
      Filed
      Feb 25, 2025
      View
      Exempt Offerings
      Offering
      $728.0K
      Filed
      May 26, 2023
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 6, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      EVH +0.9% +1.3% +44.6% +52.1% +17.5%
      SPY -2.0% +3.3% +11.2% +2.1% +11.8%
      vs SPY +2.8% -2.0% +33.5% +50.0% +5.7%
      Key facts CIK 1628908 CUSIP 30050B101 13F (30d) 180 filings 178 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)